Viewing nowUniloba Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

MFDS item code 201601638 · Approved 2016.03.28 · Insurance code 669804720
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is primarily used for patients with hypercholesterolemia and hyperlipidemia. It is used as an adjunct when dietary changes and exercise are insufficient to control primary hypercholesterolemia, particularly familial hypercholesterolemia and mixed hyperlipidemia. It is also helpful for patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia. This medication is particularly used to lower total cholesterol, LDL cholesterol, and Apo-B levels in pediatric patients with heterozygous familial hypercholesterolemia aged 10 to 17 years. It lowers total cholesterol and LDL cholesterol, thereby delaying the progression of atherosclerosis and effectively reducing the risk of cardiovascular disease, stroke, and myocardial infarction. Hence, it is used for hyperlipidemia and reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily; the dose may be adjusted as a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Ages 10 years to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, patients who are allergic to this medication, those with severely impaired liver function, those with muscle diseases, and women who are pregnant or breastfeeding should not take this medication. Additionally, care is needed for patients with severely impaired kidney function or those taking certain medications simultaneously. In particular, patients at high risk for muscle-related side effects should carefully consider dose adjustments or the necessity of administration. This medication may affect liver function; thus, patients with a history of liver disease or those who consume excessive alcohol should undergo regular liver function tests before and during treatment. If symptoms such as myalgia or muscle weakness occur, they should immediately inform their physician, and the administration of this medication may be stopped if necessary. These symptoms can rarely progress to serious muscle damage. This medication contains lactose, so patients with lactose intolerance are advised not to take it. There may be interactions with other medications during treatment, so all medications being taken should be disclosed to healthcare providers, particularly when taken with certain antivirals, antibiotics, immunosuppressants, or fibrate class medications. Women who could become pregnant should use appropriate contraception to avoid pregnancy, and if pregnancy is confirmed, they should immediately discontinue the medication. In case of overdose, there is no specific antidote, and treatment should be symptomatic along with monitoring of liver function and muscle enzyme levels. Lastly, this medication may show higher blood concentrations in Asians, so dosage adjustments may be necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help ensure the medication's effectiveness for a long time.
Pink round film-coated tablet
Domestic use - 30 tablets/box [10 tablets/PTP x 3], Domestic use - 30 tablets/bottle, Export use - 30 tablets/box [10 tablets/PTP x 3], Export use - 100 tablets/box [10 tablets/PTP x 10], Export use - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.